Medication info

Rabepara Tablet 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOralExpired
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Alpha Pharmaceutical Co., Ltd.
Appearance
Pale yellow round enteric-coated tablet
Packaging
28 tablets (14 tablets/PTP packaging x 2), 28 tablets (14 tablets/Alu Alu packaging x 2)
Approval status
Expired

MFDS item code 201902436 · Approved 2019.04.19

This product's status changed to Expired on 2024.04.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcer disease (including use with eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled as needed using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ◯ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ◯ Elderly patients Because hepatic function is often reduced, administer with caution.
Child dose
◯ Pediatric patients Safety in pediatric patients has not been established.

Ingredients

Manufacturer
Alpha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcer disease (including use with eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • digestive ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for gastric ulcers, duodenal ulcers, and erosive or ulcerative gastroesophageal reflux disease. It also relieves symptoms of gastroesophageal reflux disease and is effective for maintenance therapy through long-term treatment. In patients with digestive ulcers infected with Helicobacter pylori, it is used in conjunction with antibiotics for treatment and is beneficial for patients with Zollinger-Ellison syndrome. In other words, it is used to improve various digestive-related diseases.

How to take

Adult dose

Gastric ulcer, duodenal ulcer The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, the 20 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is required. After symptoms have resolved, subsequent symptoms may be controlled as needed using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication Patients with Helicobacter pylori infection should receive eradication therapy. Concomitant administration of this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. ◯ Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. ◯ Elderly patients Because hepatic function is often reduced, administer with caution.

Child dose

◯ Pediatric patients Safety in pediatric patients has not been established.

Precautions

This medication should not be used in patients with allergies to certain components or a history of hypersensitivity reactions. In particular, caution is required for those allergic to penicillins or macrolide antibiotics. It should also not be administered to patients taking certain heart-related medications or to pregnant or breastfeeding women. Patients with reduced liver function, elderly patients, and those with a history of drug allergies should use it cautiously. If any allergic symptoms such as skin rash or itching occur while taking this medication, discontinue it immediately. Regular blood tests are required as there may be changes in red or white blood cell counts. Liver function tests should also be conducted regularly, and if symptoms of hepatitis or jaundice occur, usage should be suspended. Rarely, heart-related side effects may occur, so symptoms such as dizziness or chest pain should be monitored. Digestive symptoms including diarrhea, abdominal pain, and nausea may occur, and in severe cases, medical consultation is required. Mental symptoms such as headache, insomnia, and anxiety may occur, so consult a specialist if symptoms are severe. Various adverse reactions such as respiratory issues, muscle pain, and skin rashes have been reported, so report any unusual symptoms. Long-term use of this medication may increase the risk of bone fractures, so caution is advised during prolonged treatment. Additionally, hypomagnesemia may occur, so magnesium levels should be checked periodically if needed. Suppression of gastric acid secretion may slightly increase the risk of bacterial infections in the stomach, so consult a doctor if diarrhea persists. Caution is advised when driving or operating machinery as drowsiness may occur. There may be interactions with other medications, so it is essential to inform your healthcare provider about any medications you are currently taking. It is safest to avoid use during pregnancy or breastfeeding. Safety in pediatric patients has not been established, so use is not recommended. In case of overdose, as there is no specific antidote, immediate medical attention is required. The medication should be swallowed whole and not chewed or crushed, and stored out of the reach of children. If there are suspicions of gastrointestinal diseases or malignant tumors, it should be used only after an accurate diagnosis, and regular check-ups are necessary for long-term use.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, increased ALT, increased AST, increased ALP, increased γ-GTP, increased LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, hematochezia, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, stomatitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, oral mucositis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, irritability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, muscle weakness in the limbs, sensory impairment, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthropathy, bursitis, muscle hypertonicity, neuralgia, single contraction, sweating, alopecia, skin dryness, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal visual field, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, increased thyroid-stimulating hormone, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, skin lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from exposure to air and moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius to preserve the medication's effectiveness and safety.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablet

Package unit

28 tablets (14 tablets/PTP packaging x 2), 28 tablets (14 tablets/Alu Alu packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.